Merck mRNA Melanoma Vaccine Shows Promise in Reducing RecurrenceOctober 26, 2026 Health 13 Views Merck presented trial data for its mRNA melanoma vaccine showing reduced recurrence and death when combined with an immunotherapy drug.
Personalised Cancer Vaccine Cuts Melanoma Death or Recurrence Risk by 42%October 23, 2026 Health 13 Views A major clinical trial shows a personalised mRNA vaccine combined with immunotherapy cuts the risk of death or melanoma recurrence by 42% in patients with advanced skin cancer.
